Ignite Creation Date:
2024-05-06 @ 3:19 PM
Last Modification Date:
2024-10-26 @ 1:47 PM
Study NCT ID:
NCT04596800
Status:
RECRUITING
Last Update Posted:
2023-10-31
First Post:
2020-10-18
Brief Title:
Prehabilitation Plus ERAS Versus ERAS in Gynecologic Oncology a Randomized Clinical Trial
Sponsor:
Instituto Brasileiro de Controle do Cancer
Organization:
Instituto Brasileiro de Controle do Cancer
Study Overview
Official Title:
Prehabilitation Plus Enhanced Recovery After Surgery Versus Enhanced Recovery After Surgery in Gynecologic Oncology a Randomized Clinical Trial
Status:
RECRUITING
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PROPER
Brief Summary:
Prospective interventionist controlled and randomized study to test the effectiveness of a multimodal prehabilitation protocol in patients who will undergo gynecological surgery
Detailed Description:
Prospective interventionist and randomized controlled trial in a 1 1 ratio open to multidisciplinary team and blind to surgeons and anaesthesiologists The aim is test the effectiveness of a multimodal prehabilitation protocol in patients who will undergo gynecological surgery
The multidisciplinary prehabilitation program will be applied to the intervention group For the group participating in the prehabilitation and for the control group specific recommendations for gynecological cancer defined by the Enhanced Recovery After Surgery ERAS guidelines will be applied
The multidisciplinary prehabilitation program will be applied to the intervention group For the group participating in the prehabilitation and for the control group specific recommendations for gynecological cancer defined by the Enhanced Recovery After Surgery ERAS guidelines will be applied
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None